 |
 |
 |
|
|
|
 |
|
 |
|
|
|
|
*If you do not have Adobe® Reader®, download it here. It is available without charge from Adobe®.
This link is prorided as a convenience, Oncolys is not responsible for the content of this page. |
|
|
|
|
 |
|
| ■Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cell |
|
|
|
| |
|
Takanori Watanabe, Masayoshi Hioki, Toshiya Fijiwara, Masahiko Nishizaki, Shunsuke Kagawa,
Masaki Taki, Hiroyuki Kishimoto, Yoshikatsu Endo, Yasuo Urata, Noriaki Tanaka, Toshiyoshi Fujiwara
Experimental Cell Research, 312:256-265, 2006
 |
|
| ■Telomerase-specific Replication-Selective Virotherapy for Human Cancer. |
|
|
|
| |
|
Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, Taki M, Kyo S,
Tanaka N, Fujiwara T.
Clinical Cancer Research, 10:285-292, Jan. 2004
|
|
|
 |
|
| ■In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus |
|
|
|
| |
|
Hiroyuki Kishimoto, Toru Kojima, Yuichi Watanabe, Shunsuke Kagawa, Toshiya Fujiwara,
Futoshi Uno, Fuminori Teraishi, Satoru Kyo, Hiroyuki Mizuguchi, Yuuri Hashimoto, Yasuo Urata,
Noriaki Tanaka & Toshiyoshi Fujiwara
Nature Medicine 12(10):1213-1219, Oct. 2006
|
|
| ■Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: Preclinical evaluation of chemovirotherapy |
|
|
|
| |
|
Toshiya Fujiwara, Shunsuke Kagawa, Hiroyuki Kishimoto, Yoshikatsu Endo, Masayoshi Hioki,
Yoshihiro Ikeda, Ryo Sakai,Yasuo Urata, Noriaki Tanaka and Toshiyoshi Fujiwara
Int. J. Cancer, 119:432-440, 2006
|
|
■Visualization of intrathoracically Disseminated Solid Tumor in Mice with Optical Imaging by Telomerase-Specific Amplification of a Transferred Green Fluorescent Protein Gene. |
|
|
|
| |
|
Umeoka T., Kawashima T., Kagawa S., Teraishi F., Taki M., Nishizaki M., Kyo S., Nagai K., Urata Y.,
Tanaka N., Fujiwara T.
Cancer Research, 64(17):6259-6265, Sep. 2004
|
|
|
 |
|
■Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2’,3’-Didehydro-3’-Deoxy-4’-Ethynylthymidine, a Novel Thymidine Analog |
|
|
|
| |
|
Elijah Paintsil, Ginger E. Dutschman, Rong Hu, Susan P. Grill, Wing Lam, Masanori Baba, Hiromichi Tanaka, and Yung-Chi Cheng
Antimicrobial Agents And Chemotherapy, 51(11):3870-3879, Nov. 2007
|
|
■Comparison of the Phosphorylation of 4'-Ethynyl 2',3‘-Dihydro-3'-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs |
|
|
|
| |
|
Chih-Hung Hsu, Rong Hu, Ginger E. Dutschman, Guangwei Yang, Preethi Krishnan, Hiromichi Tanaka, Masanori Baba, and Yung-Chi Cheng,
Antimicrobial Agents And Chemotherapy, 51(5):1687-1693, May 2007
|
|
■Anti-Human Immunodeficiency Virus Type 1 Activity and Resistance Profile of 2’,3’-Didehydro-3’-Deoxy-4’-Ethynylthymidine In Vitro |
|
|
|
| |
|
Takao Nitanda, Xin Wang, Hiroki Kumamoto, Kazuhiro Haraguchi, Hiromichi Tanaka,
Yung-Chi Cheng, and Masanori Baba
Antimicrobial Agents and Chemotherapy, 49(8):3355-3360, Aug. 2005
|
|
| ■Novel 4_-Substituted Stavudine Analog with Improved Anti-Human Immunodeficiency Virus Activity and Decreased Cytotoxicity |
|
|
|
| |
|
Ginger E. Dutschman, Susan P. Grill, Elizabeth A. Gullen, Kazuhiro Haraguchi, Shingo Takeda,
Hiromichi Tanaka, Masanori Baba, and Yung-Chi Cheng
Antimicrobial Agents And Chemotherapy, 48(5):1640-1646, May 2004
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright
(c)2004-2005, Oncolys BioPharma Inc. All rights reserved.
|
|
